awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38911022-2E94CA63-9E98-4594-A8DC-2FCB1073CA08
Q38911022-2E94CA63-9E98-4594-A8DC-2FCB1073CA08
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38911022-2E94CA63-9E98-4594-A8DC-2FCB1073CA08
Dacomitinib (PF-00299804), a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitor, demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro
P2860
Q38911022-2E94CA63-9E98-4594-A8DC-2FCB1073CA08
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38911022-2E94CA63-9E98-4594-A8DC-2FCB1073CA08
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1a3229d50f3d2276151ff807eb16f1a7afd9508d
P2860
Afatinib demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro and in vivo.